- Shao, Hui, Ji Lin, Xiaohui Zhuo, Deborah B. Rolka, Edward W. Gregg, and Ping Zhang. “Influence of Diabetes Complications on HbA1c Treatment Goals Among Older U.S. Adults: A Cost-Effectiveness Analysis.”Diabetes Care 42, no. 11 (November 1, 2019): 2136–42. https://doi.org/10.2337/dc19-0381.
- Shao, Hui, Charles Stoecker, Alisha M. Monnette, and Lizheng Shi. “Cost Sharing of Disease-Modifying Treatments (DMTs) as Policy Lever to Improve DMTs’ Access in Multiple Sclerosis.”Value in Health 21, no. 9 (September 1, 2018): 1083–89. https://doi.org/10.1016/j.jval.2017.10.025.
- Park H, Wang W, Henry L, Nelson D. Impact of all-oral direct-acting antivirals on clinical and economic outcomes in chronic hepatitis C virus-infected patients in the U.S. Hepatology 2019;69(3):1032-1045.
- Song H, Blake K, Wilson D, Winterstein A, Park H. Medical costs and productivity loss of mild, moderate, and severe asthma in the United States, 2010-2017. Journal of Allergy & Asthma 2020;13:545-555.
- Diaby V, Alqhtani H, van Boemmel-Wegmann S, Wang CY, Ali AA, Balkrishnan R, Ko Y, Palacio S, de Lima Lopes G. A cost-effectiveness analysis of trastuzumab-containing treatment sequences for HER-2 positive metastatic breast cancer patients in Taiwan. The Breast. 2020 Feb 1;49:141-8.
- Ali AA, Tawk R, Xiao H, Campbell E, Semykina A, Montero AJ, Mogos M, Diaby V. Comparative effectiveness of radiotherapy for early‐stage hormone receptor‐positive breast cancer in elderly women using real‐world data. Cancer medicine. 2019 Jan;8(1):117-27.